Susquehanna International Group
EVH icon

Susquehanna International Group’s Evolent Health EVH Stock Holding History

Susquehanna International Group’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$209K Sell
91,537
-125,810
-58% -$399K ﹤0.01% 11622
2025
Q4 		$869K Buy
217,347
+176,200
+428% +$980K ﹤0.01% 7496
2025
Q3 		$348K Sell
41,147
-181,641
-82% -$1.76M ﹤0.01% 9777
2025
Q2 		$2.51M Buy
222,788
+68,448
+44% +$629K ﹤0.01% 5320
2025
Q1 		$1.46M Sell
154,340
-75,435
-33% -$762K ﹤0.01% 6278
2024
Q4 		$2.58M Buy
229,775
+65,847
+40% +$1.16M ﹤0.01% 4741
2024
Q3 		$4.64M Buy
163,928
+33,793
+26% +$871K ﹤0.01% 3710
2024
Q2 		$2.49M Buy
130,135
+123,699
+1,922% +$3.16M ﹤0.01% 4663
2024
Q1 		$211K Sell
6,436
-29,362
-82% -$937K ﹤0.01% 10492
2023
Q4 		$1.18M Buy
+35,798
New +$1.01M ﹤0.01% 6579
2023
Q3 		– Sell
-33,735
Closed -$938K – 12253
2023
Q2 		$1.02M Sell
33,735
-7,838
-19% -$253K ﹤0.01% 6625
2023
Q1 		$1.35M Buy
41,573
+15,466
+59% +$489K ﹤0.01% 6067
2022
Q4 		$733K Sell
26,107
-4,621
-15% -$132K ﹤0.01% 6895
2022
Q3 		$1.1M Buy
30,728
+11,416
+59% +$402K ﹤0.01% 6385
2022
Q2 		$593K Buy
19,312
+308
+2% +$8.97K ﹤0.01% 7840
2022
Q1 		$614K Sell
19,004
-3,769
-17% -$98.7K ﹤0.01% 8412
2021
Q4 		$630K Sell
22,773
-128,051
-85% -$3.67M ﹤0.01% 8534
2021
Q3 		$4.68M Buy
150,824
+119,545
+382% +$2.87M ﹤0.01% 4070
2021
Q2 		$661K Buy
31,279
+14,721
+89% +$295K ﹤0.01% 8884
2021
Q1 		$334K Sell
16,558
-191,695
-92% -$3.65M ﹤0.01% 10379
2020
Q4 		$3.34M Buy
208,253
+122,305
+142% +$1.62M ﹤0.01% 4131
2020
Q3 		$1.07M Sell
85,948
-17,606
-17% -$207K ﹤0.01% 5952
2020
Q2 		$737K Buy
103,554
+59,366
+134% +$398K ﹤0.01% 6559
2020
Q1 		$240K Sell
44,188
-311,884
-88% -$2.79M ﹤0.01% 8375
2019
Q4 		$3.22M Sell
356,072
-123,698
-26% -$1M ﹤0.01% 3582
2019
Q3 		$3.45M Buy
479,770
+356,527
+289% +$2.56M ﹤0.01% 3274
2019
Q2 		$980K Buy
123,243
+83,831
+213% +$993K ﹤0.01% 5702
2019
Q1 		$496K Sell
39,412
-6,802
-15% -$108K ﹤0.01% 6294
2018
Q4 		$922K Buy
46,214
+21,294
+85% +$493K ﹤0.01% 4828
2018
Q3 		$708K Sell
24,920
-5,639
-18% -$135K ﹤0.01% 5907
2018
Q2 		$643K Sell
30,559
-3,069
-9% -$58.1K ﹤0.01% 6303
2018
Q1 		$479K Sell
33,628
-4,922
-13% -$70.5K ﹤0.01% 6719
2017
Q4 		$474K Buy
38,550
+15,736
+69% +$222K ﹤0.01% 6740
2017
Q3 		$406K Buy
+22,814
New +$470K ﹤0.01% 6888
2016
Q4 		– Sell
-33,081
Closed -$652K – 9702
2016
Q3 		$814K Buy
+33,081
New +$773K ﹤0.01% 5181
2016
Q2 		– Sell
-11,213
Closed -$118K – 8721
2016
Q1 		$118K Buy
+11,213
New +$116K ﹤0.01% 8358
2015
Q4 		– Sell
-38,757
Closed -$619K – 9542
2015
Q3 		$619K Buy
+38,757
New +$756K ﹤0.01% 6695

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group's EVH Position: Q1 2026 in Review

Susquehanna International Group reduced its Evolent Health (EVH) stake by 58% in Q1 2026, selling an estimated $399K and leaving 91,537 shares worth $209K. The position accounts for ﹤0.01% of the portfolio, ranked #11622.

Susquehanna International Group first reported a position in EVH in Q3 2015 and has held it in 37 quarters since. The position peaked at $4.68M in Q3 2021. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Susquehanna International Group held 91,537 shares of Evolent Health worth $209K as of Q1 2026.
  • Susquehanna International Group sold 125,810 Evolent Health shares in Q1 2026, an estimated $399K.
  • Evolent Health made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #11622 holding.
  • Susquehanna International Group first reported a position in Evolent Health in Q3 2015 and has held it in 37 quarters since.
  • Susquehanna International Group's Evolent Health position peaked at $4.68M in Q3 2021.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.